No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
スポンサーリンク
概要
著者
-
OHTAKE Shigeki
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
KAGEYAMA Shinichi
Department of Hematology and Oncology, Mie University Graduate School of Medicine
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
Yamada Osamu
Division of Pediatrics, National Cardiovascular Center
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
JINNAI Itsuro
Nagasaki CML Study Group
-
KURIYAMA Kazutaka
Nagasaki CML Study Group
-
SAKAMAKI Hisashi
Department of Hematology, Tokyo Metropolitan Komagome Hospital
-
OMOTO Eijiro
Second Department of Medicine, Okayama University Medical School
-
Takahashi Masatomo
Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O
-
Takahashi Masatomo
聖マリアンナ医科大学 血液･腫瘍内科
-
Takayama K
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tsukasaki Kunihiro
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Takeyama Kunihiko
東海大学 医学部
-
Takeyama Kunihiko
国立がんセンター中央病院
-
Takeyama Kunihiko
Department Of Hematology/oncology National Cancer Center Hospital
-
MINAMI Saburo
Department of Veterinary Surgery, Faculty of Agriculture, Tottori University
-
ANDO Kiyoshi
Tokai University
-
Jinnai Itsuro
長崎大学医学部歯学部附属病院 輸血部
-
Sakamaki Hisashi
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Ohno R
Aichi Cancer Center
-
Ohno Ryuzo
琉球大学 医学部血液免疫検査学分野
-
Miyawaki Shuichi
琉球大学 医学部血液免疫検査学分野
-
Miyawaki S
Division Of Hematology Tokyo Metropolitan Ohtsuka Hospital
-
Kanamaru A
Department Of Hematology Kinki University School Of Medicine
-
Ohtake S
Department Of Hematology Kanazawa University Graduate School Of Medical Science
-
Tanimoto M
Blood Transfusion Division Department Of Internal Medicine Ii Okayama University Graduate School Of
-
Tanimoto Mitsune
国立がんセンター中央病院 造血幹細胞移植グループ
-
Jinnai Itsuro
International Medical Center Saitama Medical University
-
SAITO Kenji
Department of Hematology, Dokkyo Medical School of Medicine
-
KURIYAMA Kazutaka
Department of Clinical Laboratory Sciences, Hematoimmunology, School of Health Science, Faculty of M
-
KOBAYASHI Tohru
Second Department of Internal Medicine, Mie University School of Medicine
-
TANIMOTO Mitsune
First Department of Internal Medicine, Nagoya University School of Medicine
-
TSUBAKI Kazuo
Third Department of Internal Medicine, Kinki University School of Medicine
-
OMOTO Eijiro
Department of Medicine, Okayama University Medical School
-
OH Hakumei
Second Department of Internal Medicine, Chiba University School of Medicine
-
JINNAI Itsuro
First Department of Internal Medicine, Saitama Medical School
-
KANAMARU Akihisa
Second Department of Internal Medicine, Hyogo College of Medicine
-
ASOU Norio
Second Department of Internal Medicine, Kumamoto University School of Medicine
-
KAGEYAMA Shinichi
Second Department of Internal Medicine, Mie University School of Medicine
-
TAKEYAMA Kunihiko
National Cancer Center Hospital
-
Takahashi Masatomo
St. Marianna Univ. School Of Medicine Kawasaki Jpn
-
Kageyama Shinichi
浜松医科大学 第3内科
-
Kageyama Shinichi
Department Of Hematology And Oncology Mie University Graduate School Of Medicine
-
Kitamura Kunio
名古屋大学 医学系研究科血液･腫瘍内科学
-
MIYAWAKI Shuichi
Internal Medicine,Saiseikai Maebashi Hospital
-
HATAKE Kiyohiko
Department of Hematology,Jichi Medical School
-
HIRAOKA Akira
Firtst Department of Internal Medicine,Osaka Medical Center for Cancer and Cardiovascular Diseases
-
MATSUDA Shin
Division of Hematology,Internatinal Medicine,Ohta Nisinouchi Hospital
-
TAKAHASHI Masatomo
First Department of International Medicine,St Marianna University School of Medicine
-
SHIMAZAKI Chihiro
Second Department of Medicine,Kyoto Prefectural University of Medicine
-
ADACHI Koichi
First Department of Internal Medicine,Nagoya University School of Medicine
-
SAKURA Tohru
Internal Medicine,Saiseikai Maebashi Hospital
-
OHNO Ryozo
Department of Medicine III,Hamamatsu Medical School
-
Asou Norio
愛知県がんセンター
-
Asou N
Department Of Hematology Kumamoto University School Of Medicine
-
Asou Norio
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Asou Norio
Department Of Hematology And Infectious Diseases Kumamoto University Graduate School Of Medical Scie
-
Shinagawa K
Okayama Univ. Hospital Okayama Jpn
-
Shimazaki Chihiro
Second Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Shimazaki Chihiro
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Hiraoka A
Fifth Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Hiraoka Akira
Department Of Hematology And Oncology Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Hiraoka Akira
Fifth Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Tsubaki K
Kinki Univ. School Of Medicine Osaka Jpn
-
Tsubaki Kazuo
Third Department Of Internal Medicine Kinki University School Of Medicine
-
Sakura Tohru
群馬大学 医学系研究科生体統御内科学
-
Sakura T
Department Of Medicine Saiseikai Maebashi Hospital
-
Sakura Tohru
Internal Medicine Saiseikai Maebashi Hospital
-
Murata Takashi
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Kuriyama K
Blood Immunology Laboratory School Of Health Sciences Faculty Of Medicine And University Hospital Un
-
Ohtake Shigeki
Department Of Clinical Laboratory Sciences Graduate School Of Medical Sciences Kanazawa University
-
Tomonaga Masao
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
TAKEYAMA Kunihiko
First Department of Internal Medicine, Nagoya University School of Medicine
-
Shinjo Kaori
浜松医科大学 内科学第3
-
Soda Hisashi
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Sano Masayuki
Niigata Cancer Center Hospital
-
Hatake Kiyohiko
Department Of Hematology Jichi Medical School
-
Asou Norio
Department Of Hematology Kumamoto University School Of Medicine
-
SHIMAZAKI Chihiro
Kyoto Prefecture University of Medicine
-
Minami Saburo
Department Of Veterinary Surgery Faculty Of Agriculture Tottori University
-
Matsuda Shin
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Kanamaru Akihisa
Division Of Hematology Nephrology And Rheumatology Department Of Internal Medicine Kinki University
-
Kanamaru Akihisa
Second Department Of Internal Medicine Hyogo College Of Medicine
-
Tsukasaki K
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Sakamaki H
Division Of Hematology Tokyo Metropolitan Komagome Hospital
-
Jinnai Itsuro
Division Of Hematology Department Of Internal Medicine Saitama Medical School
-
Jinnai Itsuro
First Department Of Internal Medicine Saitama Medical School
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Disease Institute Nagasaki University Gradua
-
Tomonaga Masao
Hematology Atomic Disease Institute Nagasaki University School Of Medicine
-
Miyawaki Shuichi
Saiseikai Maebashi Hospital Maebashi Jpn
-
Miyawaki Shuichi
Internal Medicine Saiseikai Maebashi Hospital
-
Shigeno Kazuyuki
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
Kobayashi Tohru
Department Of Hematopoietic Pathobiology And Medical Oncology Mie University Graduate School Of Medi
-
Shinagawa Katsushi
The Second Department Of Internal Medicine
-
Shinagawa Katsuji
Division Of Hematology/oncology Okayama University Medical School
-
Tanimoto Mitsune
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Omoto E
Okayama Univ. Medical School Okayama Jpn
-
Ohno Ryuzo
Department Of Medicine Iii Hamamatsu Medical School
-
Takahara Shinobu
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Takahashi Masatomo
First Department Of Internal Medicine St. Marianna University School Of Medicine
-
Saito Kenji
Department Of Hematology Dokkyo University School Of Medicine
-
Hiraoka Akira
Department Of Hematology/oncology Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Saito Kenji
Department Of Applied Chemistry Faculty Of Science Tokyo University Of Science
-
Shimazaki C
Kyoto Prefecture University Of Medicine
-
Kyo T
Hiroshima Red Cross Hospital & Atomic‐bomb Survivors Hospital Hiroshima Jpn
-
Kikuchi Ako
Department Of Hematology/oncology Tokai University School Of Medicine
-
Kikuchi Ako
Tokai University
-
Oh Hakumei
Second Department Of Internal Medicine Chiba University School Of Medicine
-
Takeyama K
National Cancer Center Hospital Tokyo Jpn
-
Tamura Jun'ichi
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Sakura Tohru
Division Of Hematology Saiseikai Maebashi Hospital
-
Takeyama Kunihiko
Department Of Hematology Harasanshin General Hospital
-
Sugiyama Katsuki
Division Of Hematology And Oncology Department Of Internal Medicine The Jikei University School Of M
-
Adachi Koichi
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Kanamaru Akihisa
Division Of Hematology And Oncology Department Of Medicine Tokai University School Of Medicine
-
Asano Naoko
Department Of Laboratory Medicine Shinshu University Hospital
-
Asano Naoko
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Kobayashi Tohru
Second Department Of Internal Medicine
-
Ohtake Shigeki
Department Of Clinical Laboratory Science Kanazawa University Graduate School Of Medical Science
-
Tsukasaki Kunihiro
The Department Of Haematology Of Atomic Disease Institute Nagasaki University School Of Medicine
-
Yamada Osamu
Division Of Hematology Department Of Internal Medicine Kawasaki Medical School
-
Kobayashi Takayuki
Division Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Ohtake Shigeki
Department Of Clinical Laboratory Science Kanazawa University Graduate School Kanazawa University
-
Ando Kiyoshi
Department Of Hematology And Oncology Tokai University
-
Kuriyama Kazutaka
Department Of Clinical Laboratory Sciences Hematoimmunology School Of Health Science Faculty Of Medi
-
SAITO Kenji
Department of Applied Biological Chemistry Graduate School of Agricultural and Life Sciences, The University of Tokyo
-
MINAMI Saburo
Department of Veterinary Clinical Medicine, Tottori University, 4-101 Koyama-Minami, Tottori 680-8553, Japan
-
Omoto Eijiro
Department of Hematology, Yamagata Prefectural Central Hospital, Japan
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Increased macrophage colony-stimulating factor levels in patients with Graves' disease
- Increased macrophage colony-stimulating factor levels in patients with Graves' disease
- 0291 ISOLATED NONCOMPACTION OF THE VENTRICULAL MYOCARDIUM (INVM) : CONSIDERATION OF THE DISTINCTIVE CLINICAL ENTITY
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Early Tumor Regression Following Severe Lung Injury after Allogeneic Stem Cell Transplantation in a Patient with Renal Cell Carcinoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Multiple Myeloma : Results from the Japan Myeloma Study Group
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32
- Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
- Gastric low-grade B-cell MALT lymphoma : treatment, response, and genetic alteration
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Good Prognosis of Patients With Acute Promyelocytic Leukemia Who Achieved Second Complete Remission (CR) With a New Retinoid, Am80, After Relapse From CR Induced by All-trans-Retionic Acid
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult oatients with acute lymphoblastic leukemia: The ALL-87 Study of the Japan Adult Leukemia Study Group (JALSG)
- Impact of Established Risk Factors for Breast Cancer in Nulligravid Japanese Women
- Expression profiling analysis of the CD5^+ diffuse large B-cell lymphoma subgroup : Development of a CD5 signature
- Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Senile Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders : a Mini Review
- Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese
- Multicenter Prospective Study of Interferon-α and Conventional Chemotherapy Versus Bone Marrow Transplantation for Newly Diagnosed Patients With Chronic Myelogenous Leukemia
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Effective and Safe Interferon Treatment for Japanese Patients With Chronic Myelogenous Leukemia Relapse After Bone Marrow Transplantation
- Comparison of genetic aberrations in CD10^+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization
- MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma(SLL)
- CD34^+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications
- Assessment of Prognostic Factors in Follicular Lymphoma Patients
- Association of p53 Codon Arg72Pro and p73 G4C14-to-A4T14 at Exon 2 Genetic Polymorphisms with the Risk of Japanese Breast Cancer
- Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis : A retrospective study
- Living-donor lobar lung transplantation for broncho-bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: does bronchiolitis obliterans recur in transplanted lungs?
- Refractory Crow-Fukase Syndrome (POEMS Syndrome) Successfully Treated with High-Dose Melphalan followed by Autologous Peripheral Blood Stem Cell Transplantation
- Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- Clinical Aspects of Multimodality Therapy for Resectable Locoregional Esophageal Cancer
- Physical exercise reduces risk of breast cancer in Japanese women
- Transforming Growth Factor B1 T29C Polymorphism and Breast Cancer Risk in Japanese Women
- Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia
- Treatment of acute myeloid leukemia and myelodysplastic syndrome with orally administered cytarabine ocfosfate and granulocyte colony-stimulating factor
- High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
- Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Early Detection of Plasma Cytomegalovirus DNA by Real-Time PCR after Allogeneic Hematopoietic Stem Cell Transplantation
- Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
- Novel processing techniques of pH and heat stable chitosan nano-particles
- Cellular Biological Differnces Between Human Myeloma Cell Lines KMS-12-PE and KMS-12-BM Established From a Single Patient
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- Intestinal Diffuse Large B-Cell Lymphoma Associated with Celiac Disease : A Japanese Case
- Primary cutaneous T-cell lymphoma of unspecified type with cytotoxic phenotype : Clinicopathological analysis of 27 patients
- Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders : Special references to lymphomas surrounding this newly recognized clinicopathologic disease
- Successful treatment of Aspergillus liver abscesses in a patient with acute monoblastic leukemia using combination antifungal therapy including micafungin as a key drug
- Micafungin-induced immune hemolysis attacks
- Long-term Efficacy of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor in Therapy of Aplastic Anemia
- Two Cases Showing Clonal Progression With Full Evolution From Aplastic Anemia-Paroxysmal Nocturnal Hemoglobinuria Syndrome to Myelodysplastic Syndromes and Leukemia
- Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development
- Oral Melphalan, Dexamethasone, and Thalidomide for the Treatment of Refractory Multiple Myeloma
- Ankyrin Gene Mutations in Japanese Patients With Hereditary Spherocytosis
- Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Age-related EBV-associated B-cell lymphoproliferative disorders : Diagnostic approach to a newly recognized clinicopathological entity
- Synergistic Growth Inhibition of YM529 with Biologic Response Modifiers (BRMs) in Myeloma Cells
- Multiple Myeloma Associated with Thrombocytopenia Caused by Immunological Destruction
- 904 Isolation and Characterization of Mutants of Saccharomyces cerevisiae with pH-sensitive Growth
- Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Comparison between self-reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for risk of upper aerodigestive tract cancer in a Japanese population
- LKB1 Gene Alterations in Surgically Resectable Adenocarcinoma of the Lung
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Urgent Total Arch Graft Replacement in an Elderly Patient with Acute Type A Dissection:Report of a Case
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Prognostic Factors of Pathologic Stage IB Non-small Cell Lung Cancer
- Profile of Participants and Genotype Distributions of 108 Polymorphisms in a Cross-Sectional Study of Associations of Genotypes With Lifestyle and Clinical Factors : A Project in the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
- A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- An Instructive Case Suggesting Warfarin Resistance Which is Independent on the Regulation of the CYP2C9 and VKORC1 Genotype
- Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia : continuity from carrier status to smoldering ATL
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95